Adaptive Biotechnologies Corp financial data

Symbol
ADPT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1165 Eastlake Ave E, Seattle, WA
State of incorporation
WA
Fiscal year end
December 31
Former names
Adaptive TCR Corp (to 6/2/2011)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 369 % -25.7%
Quick Ratio 13.2 % -33.8%
Debt-to-equity 144 % +48.8%
Return On Equity -67.7 % -12%
Return On Assets -27.7 % +9.77%
Operating Margin -90.8 % +31.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 149M shares +0.82%
Common Stock, Shares, Outstanding 148M shares +1.86%
Entity Public Float 416M USD -45%
Common Stock, Value, Issued 14K USD 0%
Weighted Average Number of Shares Outstanding, Basic 147M shares +1.88%
Weighted Average Number of Shares Outstanding, Diluted 147M shares +1.88%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 179M USD +5.1%
Research and Development Expense 103M USD -15.7%
Selling and Marketing Expense 84.8M USD -4.31%
General and Administrative Expense 72.8M USD -13.3%
Costs and Expenses 342M USD -14%
Operating Income (Loss) -163M USD +28.4%
Net Income (Loss) Attributable to Parent -159M USD +29.2%
Earnings Per Share, Basic -1.08 USD/shares +30.8%
Earnings Per Share, Diluted -1.08 USD/shares +30.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.9M USD -26.3%
Accounts Receivable, after Allowance for Credit Loss, Current 41.7M USD +9.91%
Inventory, Net 8.44M USD -41.6%
Assets, Current 284M USD -30.8%
Property, Plant and Equipment, Net 48.6M USD -28.7%
Operating Lease, Right-of-Use Asset 45.8M USD -12.1%
Goodwill 119M USD 0%
Other Assets, Noncurrent 2.29M USD -36.3%
Assets 539M USD -18.4%
Accounts Payable, Current 7.27M USD -5.88%
Employee-related Liabilities, Current 15.8M USD +15.7%
Accrued Liabilities, Current 8.16M USD -5.12%
Contract with Customer, Liability, Current 55.7M USD +14.5%
Liabilities, Current 98.1M USD +11.4%
Contract with Customer, Liability, Noncurrent 27.3M USD -39.2%
Operating Lease, Liability, Noncurrent 79.1M USD -11.5%
Other Liabilities, Noncurrent 20K USD
Liabilities 337M USD -4.53%
Accumulated Other Comprehensive Income (Loss), Net of Tax 166K USD -22.8%
Retained Earnings (Accumulated Deficit) -1.3B USD -13.9%
Stockholders' Equity Attributable to Parent 203M USD -34.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 202M USD -34.3%
Liabilities and Equity 539M USD -18.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -38.4M USD +35.2%
Net Cash Provided by (Used in) Financing Activities 44K USD -93.5%
Net Cash Provided by (Used in) Investing Activities 44.5M USD -29.3%
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 148M shares +1.86%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.2M USD +37.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.29M USD -17.1%
Deferred Tax Assets, Valuation Allowance 436M USD +8.22%
Deferred Tax Assets, Gross 447M USD +7.23%
Operating Lease, Liability 89.4M USD -9.5%
Depreciation 4.79M USD -4.26%
Payments to Acquire Property, Plant, and Equipment 1.51M USD -48.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -160M USD +27.8%
Lessee, Operating Lease, Liability, to be Paid 108M USD -11.3%
Property, Plant and Equipment, Gross 136M USD -3.55%
Operating Lease, Liability, Current 10.2M USD +9.11%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.3M USD -12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.1M USD +2.97%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.2M USD -19.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.9M USD -3.13%
Deferred Tax Assets, Operating Loss Carryforwards 275M USD +9.06%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 10.7M USD +15.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.3M USD +2.83%
Operating Lease, Payments 3.7M USD +8.82%
Additional Paid in Capital 1.51B USD +3.71%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD +0.24%
Deferred Tax Assets, Net of Valuation Allowance 11.6M USD -20.2%
Share-based Payment Arrangement, Expense 53.6M USD -14.8%
Interest Expense 11.6M USD -16.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%